Abstract
Mitochondrial DNA analysis plays an important role in forensic science as well as in the diagnosis of mitochondrial diseases. The occurrence of two different nucleotides at the same sequence position can be caused either by heteroplasmy or by a mix of samples. The detection of superimposed positions in forensic samples and their quantification can provide additional information and might also be useful to identify a mixed sample. Therefore, the detection and visualization of heteroplasmy has to be robust and sensitive at the same time to allow for reliable interpretation of results and to avoid a loss of information. In this study, different factors influencing the analysis of mitochondrial heteroplasmy (DNA polymerases, PCR and sequencing primers, nucleotide incorporation, and sequence context) were examined. BigDye Sanger sequencing and the SNaPshot minisequencing were compared as to the accuracy of detection using artificially created mitochondrial DNA mixtures. Both sequencing strategies showed to be robust, and the parameters tested showed to have a variable impact on the display of nucleotide ratios. However, experiments revealed a high correlation between the expected and the measured nucleotide ratios in cell mixtures. Compared to the SNaPshot minisequencing, Sanger sequencing proved to be the more robust and reliable method for quantification of nucleotide ratios but showed a lower detection sensitivity of minor cytosine components.
Similar content being viewed by others
References
Lutz S, Weisser HJ, Heizmann J, Pollak S (1996) mtDNA as a tool for identification of human remains. Identification using mtDNA. Int J Leg Med 109:205–209
Holland MM, Parsons TJ (1999) Mitochondrial DNA sequence analysis—validation and use for forensic casework. Forensic Sci Rev 11:21–50
Budowle B, Allard MW, Wilson MR, Chakraborty R (2003) Forensics and mitochondrial DNA: applications, debates, and foundations. Annu Rev Genomics Hum Genet 4:119–141
Szibor R, Plate I, Schmitter H, Wittig H, Krause D (2006) Forensic mass screening using mtDNA. Int J Leg Med 120:372–376
Wong LJC, Boles RG (2005) Mitochondrial DNA analysis in clinical laboratory diagnostics. Clin Chim Acta 354:1–20
Gocke CD, Benko FA, Rogan PK (1998) Transmission of mitochondrial DNA heteroplasmy in normal pedigrees. Hum Genet 102:182–186
Salas A, Lareu MV, Carracedo A (2001) Heteroplasmy in mtDNA and the weight of evidence in forensic mtDNA analysis: a case report. Int J Leg Med 114:186–190
Alonso A, Salas A, Albarrán C, Arroyo E, Castro A, Crespillo M, di Lonardo AM, Lareu MV, Cubría CL, Soto ML, Lorente JA, Semper MM, Palacio A, Paredes M, Pereira L, Lezaun AP, Brito JP, Sala A, Vide MC, Whittle M, Yunis JJ, Gómez J (2002) Results of the 1999–2000 collaborative exercise and proficiency testing program on mitochondrial DNA of the GEP-ISFG: an inter-laboratory study of the observed variability in the heteroplasmy level of hair from the same donor. Forensic Sci Int 125:1–7
Cavelier L, Johannisson A, Gyllensten U (2000) Analysis of mtDNA copy number and composition of single mitochondrial particles using flow cytometry and PCR. Exp Cell Res 259:79–85
Deckman KH, Levin BC, Helmerson K, Kishore RB, Reiner JE (2008) Isolation and characterization of a single mitochondrion. US patent 2008/0254530A1, pp 10–16
Gill P, Ivanov PL, Kimpton C, Piercy R, Benson N, Tully G, Evett I, Hagelberg E, Sullivan K (1994) Identification of the remains of the Romanov family by DNA analysis. Nat Genet 6:130–135
Ivanov PL, Wadhams MJ, Roby RK, Holland MM, Weedn VW, Parsons TJ (1996) Mitochondrial DNA sequence heteroplasmy in the Grand Duke of Russia Georgij Romanov establishes the authenticity of the remains of Tsar Nicholas II. Nat Genet 12:417–420
Brandstätter A, Sänger T, Lutz-Bonengel S, Parson W, Béraud-Colomb E, Wen B, Kong QP, Bravi CM, Bandelt HJ (2005) Phantom mutation hotspots in human mitochondrial DNA. Electrophoresis 26:3414–3429
Tully LA, Parsons TJ, Steighner RJ, Holland MM, Marino MA, Prenger VL (2000) A sensitive denaturing gradient-gel electrophoresis assay reveals a high frequency of heteroplasmy in hypervariable region 1 of the human mtDNA control region. Am J Hum Genet 67:432–443
Lutz-Bonengel S, Sänger T, Parson W, Müller H, Ellwart JW, Follo M, Bonengel B, Niederstätter H, Heinrich M, Schmidt U (2008) Single lymphocytes from two healthy individuals with mitochondrial point heteroplasmy are mainly homoplasmic. Int J Leg Med 122:189–197
Irwin JA, Saunier JL, Niederstätter H, Strouss KM, Sturk KA, Diegoli TM, Brandstätter A, Parson W, Parsons TJ (2009) Investigation of heteroplasmy in the human mitochondrial DNA control region: a synthesis of observations from more than 5000 global population samples. J Mol Evol 68:516–527
Macmillan C, Lach B, Shoubridge EA (1993) Variable distribution of mutant mitochondrial DNAs (tRNA(Leu[3243])) in tissues of symptomatic relatives with MELAS: the role of mitotic segregation. Neurology 43:1586–1590
Jazin EE, Cavelier L, Eriksson I, Oreland L, Gyllensten U (1996) Human brain contains high levels of heteroplasmy in the noncoding regions of mitochondrial DNA. Proc Natl Acad Sci USA 93:12382–12387
Calloway CD, Reynolds RL, Herrin GL Jr, Anderson WW (2000) The frequency of heteroplasmy in the HVII region of mtDNA differs across tissue types and increases with age. Am J Hum Genet 66:1384–1397
Lacan M, Thèves C, Amory S, Keyser C, Crubézy E, Salles JP, Ludes B, Telmon N (2009) Detection of the A189G mtDNA heteroplasmic mutation in relation to age in modern and ancient bones. Int J Leg Med 123:161–167
Michikawa Y, Mazzucchelli F, Bresolin N, Scarlato G, Attardi G (1999) Aging-dependent large accumulation of point mutations in the human mtDNA control region for replication. Science 286:774–779
Sanger F, Nicklen S, Coulson AR (1977) DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 74:5463–5467
Cassandrini D, Calevo MG, Tessa A, Manfredi G, Fattori F, Meschini MC, Carrozzo R, Tonoli E, Pedemonte M, Minetti C, Zara F, Santorelli FM, Bruno C (2006) A new method for analysis of mitochondrial DNA point mutations and assess levels of heteroplasmy. Biochem Biophys Res Commun 342:387–393
Köhnemann S, Pfeiffer H (2010) Application of mtDNA SNP analysis in forensic casework. Forensic Sci Int Genet. doi:10.1016/j.fsigen.2010.01.015
Köhnemann S, Sibbing U, Pfeiffer H, Hohoff C (2008) A rapid mtDNA assay of 22 SNPs in one multiplex reaction increases the power of forensic testing in European Caucasians. Int J Leg Med 122:517–523
Brandstätter A, Parson W (2003) Mitochondrial DNA heteroplasmy or artefacts—a matter of the amplification strategy? Int J Leg Med 117:180–184
Andrews RM, Kubacka I, Chinnery PF, Lightowlers RN, Turnbull DM, Howell N (1999) Reanalysis and revision of the Cambridge reference sequence for human mitochondrial DNA. Nat Genet 23:147
Wong LJ, Scaglia F, Graham BH, Craigen WJ (2010) Current molecular diagnostic algorithm for mitochondrial disorders. Mol Genet Metab 100:111–117
Kolocheva TI, Nevinsky GA, Volchkova VA, Levina AS, Khomov VV, Lavrik OI (1989) DNA polymerase I (Klenow fragment): role of the structure and length of a template in enzyme recognition. FEBS Lett 248:97–100
Parker LT, Deng Q, Zakeri H, Carlson C, Nickerson DA, Kwok PY (1995) Peak height variations in automated sequencing of PCR products using Taq dye-terminator chemistry. Biotechniques 19:116–121
Rosenblum BB, Lee LG, Spurgeon SL, Khan SH, Menchen SM, Heiner CR, Chen SM (1997) New dye-labeled terminators for improved DNA sequencing patterns. Nucleic Acids Res 25:4500–4504
Ronaghi M, Karamohamed S, Pettersson B, Uhlén M, Nyrén P (1996) Real-time DNA sequencing using detection of pyrophosphate release. Anal Biochem 242:84–89
Andréasson H, Nilsson M, Budowle B, Frisk S, Allen M (2006) Quantification of mtDNA mixtures in forensic evidence material using pyrosequencing. Int J Leg Med 120:383–390
Bai RK, Wong LJ (2004) Detection and quantification of heteroplasmic mutant mitochondrial DNA by real-time amplification refractory mutation system quantitative PCR analysis: a single-step approach. Clin Chem 50:996–1001
Oberacher H, Niederstätter H, Parson W (2007) Liquid chromatography–electrospray ionization mass spectrometry for simultaneous detection of mtDNA length and nucleotide polymorphisms. Int J Leg Med 121:57–67
Satoh M, Kuroiwa T (1991) Organization of multiple nucleoids and DNA molecules in mitochondria of a human cell. Exp Cell Res 196:137–140
Acknowledgments
This study was funded by the state of Baden-Württemberg (Competence Centre “Legal Medicine”).
Author information
Authors and Affiliations
Corresponding author
Electronic supplementary material
Below is the link to the electronic supplementary material.
Online Resource 1
Primers for PCR, Sanger sequencing, and SNaPshot minisequencing used in this study. (PDF 14 kb)
Online Resource 2
Nucleotide incorporation and display of heteroplasmy at position 16093. (PDF 1.78 mb)
Rights and permissions
About this article
Cite this article
Naue, J., Sänger, T., Schmidt, U. et al. Factors affecting the detection and quantification of mitochondrial point heteroplasmy using Sanger sequencing and SNaPshot minisequencing. Int J Legal Med 125, 427–436 (2011). https://doi.org/10.1007/s00414-011-0549-6
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00414-011-0549-6